This article is more than 5 years old. Information may no longer be current.

Eyeonics revenue up 51% in third quarter

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

ALISO VIEJO, Calif. — Third quarter sales for eyeonics increased 51%, to $5 million, from last year’s third quarter, according to the company. Eyeonics attributed the increase to sales of its accommodating IOL, the crystalens.

According to a press release from the company, as of Sept. 30, 450 ophthalmic surgeons are using the lens, an increase of 40% from May. The Centers for Medicaid and Medicare Services revised its reimbursement policy during May to allow patients the option of choosing the crystalens and reimbursing physicians for a portion of the surgery.

During the third quarter, the company also doubled its manufacturing facility in Southern California, announced plans to triple its sales force and began exploring the potential for an initial public offering of common shares of stock.

Eyeonics also launched the crystalens SE during the quarter. The SE is a biconvex silicone plate lens with a 4.5 mm optic. The lens has a 360° square edge on the posterior side of the lens.